69 ICED c

MWLMLLLMML JILL“ 35525115

zméaweLma, ou/ﬁm/MLCLCL’CWMDOB
SILL? MQZUL CALMCIKLI 0M: C

777777 9%: 6/7/ﬂ/
UUI0132072254-6F27-43F9 BABB- A4FM31RA4elana
V° Pilll I IIIIIIIIIIII‘iIIII‘II Ed
II IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
i IIIIIIIIIIIIIIII

II |
llllllllllllllllllllll ||||||l|l|||||l|||
III III II |||l|l||||||||| PATHOLOGY REPORT:

   

 

PRIMARY SITE: Stomach (Cardia)

l - "Gastrectomy" 2 - "Greater omentum" and 4 — "Standardization":
Adenocarcinoma characterized thus:
Location: cardia.
Borman Classiﬁcation: Type III
Histolo ical attern observed: ‘ W ' W’-
gTubElar ’_ {PM T'ggl [00°Z +oLJ>wa 54,1, by, 0665 Pwl‘ftj‘éw
- Solid
- Villous
Histologic grade: III - poorly differentiated
Lauren's classiﬁcation: intestinal pattern
Ulceration: present
Type of tumor invasion: spiculate
' Inﬂammatory reaction: moderate
Tumor implantation in peri-visceral adipose tissue: not detected
Proximal and distal margins: absence of neoplastic involvement.
Neural inﬁltration and blood vascular invasion: not detected
Lymphatic vascular invasion: present
Greater omentum: absence of neoplastic involvement
Lymph nodes: Involved, without capsular transposition
Lymph node conglomerates: Undetected
List of involved/dissected lymph nodes: 12/36
Discrimination lymph according to standardization, . jratio involved/ dissected):
F - Chain 1 - right paracardic: 1/4
G - Chain 2 - left paracardic: 0/3
H - Chain 3 - along the lesser curvature: 7/10
I - Chain 4sa - along the short gastric vessels: 0/0
J - Chain 4sb - along the leﬁ gastroepiploic vessels: 0/0
K - Chain 4d - along the right gastroepiploic vessels: O/l
L - Chain 5 - suprapylorics: 0/0
M - Chain 6 — infrapylorics: 0/8
N- Chain 7- along the left gastric artery: 3/3
0- Chain 8a- along the anterior hepatic artery (antero superior group): 0/2
Q- Chain 9- around the celiac trunk: l/4
S- Chain llp- along the proximal splenic artery: 0/1

3 - "Esophageal margin": Absence of neoplastic involvement.

ADDENDUM— Neoplasia affects from the sub—mucosa until the serosa and adjacent mesenteric fat.

The peritoneal lining Is integrate. .
PM KS, 4% Maw [fa/m. {Wu/in)

 

 

  
  

 

Pathological staging: pT3 pN3a TO @A {Mm *7 5‘"
V604“ W“? CW - 15444
mam al’l / 5 as i No
:Eagnosnfixtﬂqilo 6 /d (OW Vl/ _ _ _;.__ f
r: all '0 ’v __ “44...“:
_ __ __ /
v 71/

 

 

 

 

 

LC 33%};7 ”El

 

 

fgs pmbbnst cmtimu l00 0er

 

 

 

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

V4. 00

 

 

 

 

 

Insmuxisms; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provzded on the
Case Quality Control Form completed for the submitted case.

 

 

 

 

Tissue Source Site (TSS): __ TSS identiﬁer: T55 Unique Patient Identiﬁer: ___.: a
Completed By (Interviewer Name on OpenClinica): — Completed Date: ,
[Diagnosis information
it Data Element Entry Alternatives Workinﬂnstructions
Provide the diagnosis/ histologic subtype‘gstg’dgcumfntecri on
Patholo 'C Dia nosis ‘ the initial pathology report for this case. i ‘ 9 mo ogy or
1 Providing; on [ngma] M this case is mixed. provide all listed subtypes.
pamoiogy Report Villous Adenocarcmoma

 

Histologic features of
2 the sample provided
for TCGA. as reﬂected
on the CQCF.

 

Tubular (100%)

Provide the histologic features selected on the TCGA Case
Quality Control Form completed forthis case.

 

 

Discrepancy between Patholo

gy Report and Case Quality Control Form

 

3 Provide the reason for
the discrepancy
between the pathology
report and the TCGA
Case Quality Control
Form.

Case was reviewed based on
top slide to be sent to BCR

Provide a reason describing why the diagnosis on the initial
paihologv report for this case is not consistent With the
diagnosis selected on the TCGA Case Quality Control Form.

 

Name ofTSS Reviewing
4 Pathologist or

 

 

 

 

Biorepository Director

 

Provide the name of the pathologist who revrewed this case
i or TCGA.

 

 

I acknowledge that the above infer-niacin" provided by my lnstiwuoa is true and correct and has been quality controlled.

 

 

TSS Reviewing Pathologist or Biorepository Director

I acknowledge that the above information provided by my institution ls true and correct and has been quality Lona-oiled. The Atten
Went Chairman has been Informed M It more afthe above discrepancy In diagnoses.

 

Principallnvesugator Signature V

moviev.erI-I:1Im_ ﬁm‘fﬂ‘m‘ ! i 113 (<[.=§=___ _

Date

 

 

 

 

 

 

   

 

 

 

 

 

ding Pathologist or the
Date ’
l

1“: m I ~a 4 i
)iagnosis Distrepancy ' ‘1
I ryTumor Siir UIW'EIJHCY — .. V— 4
pencv .; ~

Igwanrv History I l]

, anon; PrimIirvic'e' I /

'zm “(am ' oﬁuzrﬁo .' msoununru

 

 

 

 

